IFNG and dengue disease: Synthetic glucosidase inhibitors (DNJ derivatives) have been reported to modulate Interferon gamma and TNFα receptor signalling in Dengue virus infection in primary human macrophages; this is possibly related to N-linked glycosylation changes [20].